Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Dissimilar Impact of a Mediterranean Diet and Physical Activity on Anthropometric Indices: A Cross-Sectional Study from the ILERVAS Project.

Sánchez M, Sánchez E, Hernández M, González J, Purroy F, Rius F, Pamplona R, Farràs-Sallés C, Gutiérrez-Carrasquilla L, Fernández E, Bermúdez-López M, Salvador J, Salas-Salvadó J, Lecube A; ILERVAS project collaborators.

Nutrients. 2019 Jun 17;11(6). pii: E1359. doi: 10.3390/nu11061359.

2.

An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients.

Bermudez-Lopez M, Forne C, Amigo N, Bozic M, Arroyo D, Bretones T, Alonso N, Cambray S, Del Pino MD, Mauricio D, Gorriz JL, Fernandez E, Valdivielso JM.

Expert Opin Ther Targets. 2019 Jul;23(7):619-630. doi: 10.1080/14728222.2019.1620206. Epub 2019 May 23.

PMID:
31100024
3.

The rs1126616 Single Nucleotide Polymorphism of the Osteopontin Gene Is Independently Associated with Cardiovascular Events in a Chronic Kidney Disease Cohort.

Cambray S, Galimudi RK, Bozic M, Bermúdez-López M, Rodríguez I, Valdivielso JM.

J Clin Med. 2019 Apr 29;8(5). pii: E592. doi: 10.3390/jcm8050592.

4.

Association of Candidate Gene Polymorphisms With Chronic Kidney Disease: Results of a Case-Control Analysis in the Nefrona Cohort.

Valls J, Cambray S, Pérez-Guallar C, Bozic M, Bermúdez-López M, Fernández E, Betriu À, Rodríguez I, Valdivielso JM.

Front Genet. 2019 Feb 26;10:118. doi: 10.3389/fgene.2019.00118. eCollection 2019.

5.

Skin Autofluorescence Measurement in Subclinical Atheromatous Disease: Results from the ILERVAS Project.

Sánchez E, Betriu À, Yeramian A, Fernández E, Purroy F, Sánchez-de-la-Torre M, Pamplona R, Miquel E, Kerkeni M, Hernández C, Simó R, Lecube A; ILERVAS project; ILERVAS Project:, Hernández M, Rius F, Polanco D, Barbé F, Torres G, Suárez G, Portero-Otin M, Jové M, Colàs-Campàs L, Benabdelhak I, Farràs C, Ortega M, Manuel Valdivielso J, Bermúdez-López M, Martínez-Alonso M.

J Atheroscler Thromb. 2019 Mar 6. doi: 10.5551/jat.47498. [Epub ahead of print]

6.

Peritoneal Dialysis Is an Independent Factor Associated to Lower Intima Media Thickness in Dialysis Patients Free From Previous Cardiovascular Disease.

Borràs M, Cambray S, Crespo-Masip M, Pérez-Fontán M, Bozic M, Bermudez-López M, Fernández E, Betriu À, Valdivielso JM.

Front Physiol. 2018 Dec 4;9:1743. doi: 10.3389/fphys.2018.01743. eCollection 2018.

7.

Association of the rs495392 Klotho polymorphism with atheromatosis progression in patients with chronic kidney disease.

Valdivielso JM, Bozic M, Galimudi RK, Bermudez-López M, Navarro-González JF, Fernández E, Betriu À; NEFRONA investigators.

Nephrol Dial Transplant. 2018 Jul 13. doi: 10.1093/ndt/gfy207. [Epub ahead of print]

PMID:
30010839
8.

Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients.

Bozic M, Betriu A, Bermudez-Lopez M, Ortiz A, Fernandez E, Valdivielso JM; NEFRONA investigators.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):577-584. doi: 10.2215/CJN.07980717. Epub 2018 Mar 8.

9.

Beyond the traditional lipid parameters in chronic kidney disease.

Bermúdez-López M, Betriu À, Valdivielso JM, Bretones Del Pino T, Arroyo D, Fernández E.

Nefrologia. 2018 Mar - Apr;38(2):109-113. doi: 10.1016/j.nefro.2017.09.008. Epub 2017 Nov 11. English, Spanish. No abstract available.

10.

Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound.

Valdivielso JM, Betriu A, Martinez-Alonso M, Arroyo D, Bermudez-Lopez M, Fernandez E; NEFRONA investigators.

PLoS One. 2017 Oct 18;12(10):e0186665. doi: 10.1371/journal.pone.0186665. eCollection 2017.

11.

New perspectives on CKD-induced dyslipidemia.

Bermúdez-López M, Arroyo D, Betriu À, Masana L, Fernández E, Valdivielso JM.

Expert Opin Ther Targets. 2017 Oct;21(10):967-976. doi: 10.1080/14728222.2017.1369961. Epub 2017 Aug 28. Review.

PMID:
28829206
12.

Detection of Cohesin SUMOylation In Vivo.

Bermúdez-López M, Aragón L.

Methods Mol Biol. 2017;1515:55-64.

PMID:
27797073
13.

Smc5/6 complex regulates Sgs1 recombination functions.

Bermúdez-López M, Aragon L.

Curr Genet. 2017 Jun;63(3):381-388. doi: 10.1007/s00294-016-0648-5. Epub 2016 Sep 23. Review.

14.

Sgs1's roles in DNA end resection, HJ dissolution, and crossover suppression require a two-step SUMO regulation dependent on Smc5/6.

Bermúdez-López M, Villoria MT, Esteras M, Jarmuz A, Torres-Rosell J, Clemente-Blanco A, Aragon L.

Genes Dev. 2016 Jun 1;30(11):1339-56. doi: 10.1101/gad.278275.116.

15.

ATPase-dependent control of the Mms21 SUMO ligase during DNA repair.

Bermúdez-López M, Pociño-Merino I, Sánchez H, Bueno A, Guasch C, Almedawar S, Bru-Virgili S, Garí E, Wyman C, Reverter D, Colomina N, Torres-Rosell J.

PLoS Biol. 2015 Mar 12;13(3):e1002089. doi: 10.1371/journal.pbio.1002089. eCollection 2015 Mar.

16.

A SUMO-dependent step during establishment of sister chromatid cohesion.

Almedawar S, Colomina N, Bermúdez-López M, Pociño-Merino I, Torres-Rosell J.

Curr Biol. 2012 Sep 11;22(17):1576-81. doi: 10.1016/j.cub.2012.06.046. Epub 2012 Jul 5.

17.

The Smc5/6 complex is required for dissolution of DNA-mediated sister chromatid linkages.

Bermúdez-López M, Ceschia A, de Piccoli G, Colomina N, Pasero P, Aragón L, Torres-Rosell J.

Nucleic Acids Res. 2010 Oct;38(19):6502-12. doi: 10.1093/nar/gkq546. Epub 2010 Jun 22.

Supplemental Content

Loading ...
Support Center